43rd General Practice and Primary Care update

Amanda Adler, MD, PhD, FRCP is Professor of Diabetic Medicine and Health Policy at Oxford University where she directs the Diabetes Trials Unit. She trained in economics, medicine, epidemiology, pharmacoepidemiology and pharmacovigilance. From 2009 until 2021, she chaired a Technology Appraisal Committee at the National Institute for Health and Care Excellence (NICE) and has evaluated over 130 drugs and devices across all disease areas. With NICE, she also chaired the committee for new models to evaluate and purchase antimicrobials in the setting of antimicrobial resistance, the In Vitro Advisory Group, the Clinical Guidelines for Newer Agents for Type 2 Diabetes, and the first Quality Standard for Diabetes. Recently, she represented NICE in meetings with the Ukrainian Ministry of Health.  In 2019, Professor Adler received an award for Distinguished Contribution to NICE at the Parliamentary ceremony celebrating NICE’s 20th anniversary.  She sees patients at Addenbrooke's and Royal Papworth hospitals in Cambridge.  She is a Commissioner on the Commission on Human Medicines (CHM) and chairs its Cardiovascular, Diabetes, Renal, Respiratory and Allergy Expert Advisory Group.

Chris started his career in healthcare at the University of Edinburgh, where he studied for both his medical degree and BSc in Neuroscience. In 2015, while working full-time in anaesthetics, Chris joined the NHS England Clinical Entrepreneur programme and founded Q doctor, going on to set precedents in video consulting nationwide across health and social care. In 2021 Q doctor was acquired by eConsult, where Chris is now Chief Medical Officer. In this role Chris oversees millions of online consultations, and is using the latest in technology to join up healthcare journeys more effectively. Chris also advises early stage startups (Techstars, CEP) and lectures on digital health.

Professor Partha Kar is National Specialty Advisor, Diabetes with NHS England and co-author of the national Diabetes GIRFT report.

He has been a Consultant in Diabetes and Endocrinology at Portsmouth Hospitals NHS Trust since 2008- and pioneer of the Super Six Diabetes Model which is recognised as one of the good examples of integrated care.

He has helped to expand use of technology in Type 1 Diabetes- namely use of Flash Glucose in Type 1 Diabetes and CGM in Type 1Diabetes pregnancy along with online digital self-management platforms- while recently leading on real world data collection on Closed Loops for subsequent NICE review. He has worked subsequently with NICE on updating relevant guidelines in non-invasive glucose monitoring access in Type 1 and Type 2 Diabetes.

His other work has involved introduction of frailty into QoF treatment targets, Diabulimia pilot projects in the NHS; championing “Language Matters” and helping to create an overview of Diabetes care in Primary Care Networks. Recent work has focussed on transitional care models- as well as tackling inequalities in technology access based on deprivation and ethnicity.

He is one of the leading users of social media in diabetes care – and writes a monthly blog for the British Medical Journal.

Beyond diabetes, he also recently taken a role in tackling issues of racial disparity in the medical workforce as the Medical Workforce Race Equality Standard lead for NHS England. He has also been named as one of the most influential BAME individuals in healthcare in 2020,2021 and 2022.